• Skip to primary navigation
  • Skip to main content
  • Skip to footer

HepVu

HepVu

An estimated 3.5 million people in the U.S. are living with chronic Hepatitis C infection.

  • View the Map
  • Local Data
  • Find Services
  • News & Updates
  • Events
  • Tools & Resources
Home News & Updates Opioids

Opioids

Categories:

Awareness Days Blogs & Q&As HepVu Updates What's New in Viral Hepatitis Hep A Hep B Hep C Opioids COVID-19

December 14, 2022

2022: A Year in Review

December 12, 2022

HepVu Adds 2020 County-Level Opioid Maps and Data

Read More

August 11, 2022

What's New in Viral Hepatitis - August 2022

Read More

April 27, 2022

HepVu Adds 2020 State-Level Opioid Maps and Data

Read More

March 21, 2022

Combatting Hepatitis C Among People Who Use Drugs in Appalachia

Read More

June 7, 2021

What’s New in Viral Hepatitis – June 2021

Read More

May 19, 2021

Patient Perspective on the Challenges of Treatment Restrictions in Hepatitis C Care

Read More

May 19, 2021

Dr. Lesley Miller on the Impact of Hepatitis C Treatment Restrictions on Patient Care

Read More

May 19, 2021

CHLPI and NVHR on the State of Hepatitis C Treatment Restrictions

Read More

March 25, 2021

Dr. Gregory Dore on Hepatitis C Treatment Barriers Among People Who Inject Drugs

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4

Sign up for HepVu updates.

Footer

AIDSVu HepVu

HepVu is presented by Emory University’s Rollins School of Public Health in partnership with Gilead Sciences, Inc.

  • About
  • FAQ
  • Data Methods
  • Datasets

Questions?
Info@HepVu.org

Media Inquiries
(202) 854-0480
Media@HepVu.org

Follow Us

  • Facebook
  • Twitter

© 2023 HepVu. All Rights Reserved.

  • Privacy Policy
  • Contact Us

Get HepVu in Your Inbox

Sign up to stay informed on new data, maps, expert Q&As, and infographics about Hepatitis C and opioids where you live.